BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 19788455)

  • 1. Albumin dialysis molecular adsorbents recirculating system: impact of dialysate albumin concentration on detoxification efficacy.
    Drexler K; Baustian C; Richter G; Ludwig J; Ramlow W; Mitzner S
    Ther Apher Dial; 2009 Oct; 13(5):393-8. PubMed ID: 19788455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin.
    Chawla LS; Georgescu F; Abell B; Seneff MG; Kimmel PL
    Am J Kidney Dis; 2005 Mar; 45(3):e51-6. PubMed ID: 15754264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis--a retrospective analysis.
    Kortgen A; Rauchfuss F; Götz M; Settmacher U; Bauer M; Sponholz C
    Ther Apher Dial; 2009 Oct; 13(5):419-25. PubMed ID: 19788459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.
    Evenepoel P; Laleman W; Wilmer A; Claes K; Kuypers D; Bammens B; Nevens F; Vanrenterghem Y
    Artif Organs; 2006 Apr; 30(4):276-84. PubMed ID: 16643386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow continuous ultrafiltration with bound solute dialysis.
    Patzer JF; Safta SA; Miller RH
    ASAIO J; 2006; 52(1):47-58. PubMed ID: 16436890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A pilot study of using pure albumin as a dialysate in the treatment of liver failure].
    Liu Q; Peng L; Du Y; Li M; Jia N; Zou HQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Oct; 17(10):599-602. PubMed ID: 16259917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective bilirubin reduction by single-pass albumin dialysis in liver failure.
    Boonsrirat U; Tiranathanagul K; Srisawat N; Susantitaphong P; Komolmit P; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Artif Organs; 2009 Aug; 33(8):648-53. PubMed ID: 19624591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin dialysis: single pass vs. recirculation (MARS).
    Peszynski P; Klammt S; Peters E; Mitzner S; Stange J; Schmidt R
    Liver; 2002; 22 Suppl 2():40-2. PubMed ID: 12220302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD).
    Sauer IM; Goetz M; Steffen I; Walter G; Kehr DC; Schwartlander R; Hwang YJ; Pascher A; Gerlach JC; Neuhaus P
    Hepatology; 2004 May; 39(5):1408-14. PubMed ID: 15122770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of octanoate concentrations during extracorporeal albumin dialysis treatments.
    Klammt S; Koball S; Hickstein H; Gloger M; Henschel J; Mitzner S; Stange J; Reisinger EC
    Ther Apher Dial; 2009 Oct; 13(5):437-43. PubMed ID: 19788462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease.
    Sen S; Felldin M; Steiner C; Larsson B; Gillett GT; Olausson M; Williams R; Jalan R
    Liver Transpl; 2002 Oct; 8(10):962-7. PubMed ID: 12360442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant decrease in dialysate albumin concentration during molecular adsorbent recirculating system (M.A.R.S.) therapy.
    Gong D; Ji D; Ren B; Tao J; Xu B; Ronco C; Li L
    Int J Artif Organs; 2008 Apr; 31(4):333-9. PubMed ID: 18432590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure--a prospective, randomised crossover study.
    Sponholz C; Matthes K; Rupp D; Backaus W; Klammt S; Karailieva D; Bauschke A; Settmacher U; Kohl M; Clemens MG; Mitzner S; Bauer M; Kortgen A
    Crit Care; 2016 Jan; 20():2. PubMed ID: 26728364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin.
    Lee KH; Wendon J; Lee M; Da Costa M; Lim SG; Tan KC
    Liver Transpl; 2002 Jul; 8(7):591-3. PubMed ID: 12089711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of bilirubin and bromosulphthalein to albumin: implications for understanding the pathophysiology of liver failure and its management.
    Steiner C; Sen S; Stange J; Williams R; Jalan R
    Liver Transpl; 2004 Dec; 10(12):1531-8. PubMed ID: 15558653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles of bound solute dialysis.
    Patzer J
    Ther Apher Dial; 2006 Apr; 10(2):118-24. PubMed ID: 16684212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging indications for albumin dialysis.
    Sen S; Williams R; Jalan R
    Am J Gastroenterol; 2005 Feb; 100(2):468-75. PubMed ID: 15667509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin regeneration in liver support-comparison of different methods.
    Mitzner S; Klammt S; Stange J; Schmidt R
    Ther Apher Dial; 2006 Apr; 10(2):108-17. PubMed ID: 16684211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of an albumin dialysate hemodiafiltration system for the clearance of unconjugated bilirubin.
    Awad SS; Rich PB; Kolla S; Younger JG; Reickert CA; Downing VP; Bartlett RH
    ASAIO J; 1997; 43(5):M745-9. PubMed ID: 9360145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain].
    Avilés J; Macía M; Morales S; Pérez F; Moreno A; Navarro J; Navazo L; García J
    Nefrologia; 2001; 21(4):376-85. PubMed ID: 11816514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.